Directory

>

Shelley Suggett

avatar

Shelley Suggett

Executive Director, Regulatory CMC | NGM Biopharmaceuticals

San Francisco, California, United States

View contact details (it's free)

Shelley Suggett

Summary

Shelley Suggett is an accomplished Executive Director in Regulatory CMC at NGM Biopharmaceuticals, with extensive experience in the biopharmaceutical and biotechnology sectors. She has a robust background in biochemistry and has transitioned from academia to industry, focusing on drug development and regulatory affairs. Shelley's work has led to significant contributions in the field, including patents for antibody development and published research in various scientific journals. Her passion for improving patient outcomes is evident in her memorable experiences during clinical trials, such as witnessing the positive impact of Lucentis on a patient's vision. With a strong foundation in both regulatory compliance and supply chain risk management, she is dedicated to leveraging her expertise to drive innovation and deliver value in the pharmaceutical industry. Shelley also serves as an adjunct professor, sharing her knowledge with the next generation of professionals. Her leadership and strategic insights continue to shape the future of drug development.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Shelley Suggett

Work Experience

company logo

Executive Director, Regulatory CMC at

NGM Biopharmaceuticals

January 2021 - Present

company logo

Adjunct Professor Berkeley Extension at

The University California Berkeley

September 2019 - Present

company logo

Principal Consultant at

Themistry, Inc.

January 2019 - December 2021

company logo

Adjunct Professor, Dept of Business at

San Francisco State University

January 2019 - October 2021

company logo

Senior Director Regulatory Affairs at

Halozyme, Inc.

May 2018 - January 2019

company logo

Deputy Director, Global Regulatory Affairs at

Bayer AG

February 2012 - May 2018

company logo

Director of Regulatory Affairs at

Peregrine Pharmaceuticals

July 2010 - January 2012

company logo

Global Product Supply Chain Leader at

Genentech Foundation

April 2007 - July 2010

company logo

Sr Manager/Sr. Scientist, Regulatory Affairs at

Genentech Foundation

August 2000 - April 2007

company logo

Research Associate at

Genentech Foundation

May 1995 - August 2000

company logo

Research Associate at

J David Gladstone Institutes

December 1992 - December 1994

company logo

Research Associate, Immunology, College of Veterinary Medicine at

Uppsala Universitet

August 1991 - June 1992

Logos provided by Logo.dev

Shelley Suggett

Education

San Francisco State University, Master Of Business Administration

January 2017 - January 2018

California Polytechnic State University, San Luis Obispo, Bachelor Of Science - Bs

January 1989 - January 1992

Frequently Asked Questions about Shelley Suggett

What is Shelley Suggett email address?

Shelley Suggett's primary email address is ********@ngmbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Shelley Suggett work for?

Shelley Suggett is a Executive Director, Regulatory CMC at NGM Biopharmaceuticals, a company specializing in Commercial physical research.

Where Shelley Suggett graduated from?

Shelley Suggett holds a degree in Business Administration, Management And Operations from San Francisco State University.

How can I directly contact Shelley Suggett?

To contact Shelley Suggett directly, you can use the email address ********@ngmbio.com. Complete contact information is available upon registration with Muraena.

Who is Shelley Suggett?

Shelley Suggett is an accomplished Executive Director in Regulatory CMC at NGM Biopharmaceuticals, with extensive experience in the biopharmaceutical and biotechnology sectors. She has a robust background in biochemistry and has transitioned from academia to industry, focusing on drug development and regulatory affairs. Shelley's work has led to significant contributions in the field, including patents for antibody development and published research in various scientific journals. Her passion for improving patient outcomes is evident in her memorable experiences during clinical trials, such as witnessing the positive impact of Lucentis on a patient's vision. With a strong foundation in both regulatory compliance and supply chain risk management, she is dedicated to leveraging her expertise to drive innovation and deliver value in the pharmaceutical industry. Shelley also serves as an adjunct professor, sharing her knowledge with the next generation of professionals. Her leadership and strategic insights continue to shape the future of drug development.

Shelley`s contact details

mail

********@ngmbio.com

Colleagues

avatar
Anthony Kuhlmann

Vice President, Head of Legal

avatar
Mike Sherrill

Executive Director, Project Management

avatar
Kara Calhoun

Vice President, CMC & Process Development

Kefei Zhou

VP Head of Biometrics

avatar
Daniel Kaplan

Chief Scientific Officer

avatar
Joanne Sloan Lancaster

Vice President, Clinical Development

avatar
Hsiao Lieu Dfacc

CMO and Executive VP

avatar
Carole Ho

Director Board Of Directors

avatar
William Chang

Vice President, Clinical Operations

View Contact details (it's free)
Request Profile Removal